[go: up one dir, main page]

EP1935417A4 - Composition à utiliser pour la prévention d'un état hypoglycémique - Google Patents

Composition à utiliser pour la prévention d'un état hypoglycémique

Info

Publication number
EP1935417A4
EP1935417A4 EP06798483A EP06798483A EP1935417A4 EP 1935417 A4 EP1935417 A4 EP 1935417A4 EP 06798483 A EP06798483 A EP 06798483A EP 06798483 A EP06798483 A EP 06798483A EP 1935417 A4 EP1935417 A4 EP 1935417A4
Authority
EP
European Patent Office
Prior art keywords
composition
hypoglykemic
preventing
conditions
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06798483A
Other languages
German (de)
English (en)
Japanese (ja)
Other versions
EP1935417A1 (fr
Inventor
Masako Doi
Ippei Yamaoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Publication of EP1935417A1 publication Critical patent/EP1935417A1/fr
Publication of EP1935417A4 publication Critical patent/EP1935417A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

La présente invention concerne une composition à utiliser pour la prévention d'un état hypoglycémique, la matière active de ladite composition comprenant au moins un composé choisi parmi un acide aminé ramifié, un de ses sels pharmaceutiquement acceptables et un dérivé de l'acide aminé ou du sel. La composition peut favoriser l'absorption d'un saccharide dans les cellules du cerveau afin d'éviter un état hypoglycémique.
EP06798483A 2005-10-12 2006-09-29 Composition à utiliser pour la prévention d'un état hypoglycémique Withdrawn EP1935417A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005298089 2005-10-12
PCT/JP2006/319574 WO2007043363A1 (fr) 2005-10-12 2006-09-29 Composition à utiliser pour la prévention d'un état hypoglycémique

Publications (2)

Publication Number Publication Date
EP1935417A1 EP1935417A1 (fr) 2008-06-25
EP1935417A4 true EP1935417A4 (fr) 2009-06-10

Family

ID=37942609

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06798483A Withdrawn EP1935417A4 (fr) 2005-10-12 2006-09-29 Composition à utiliser pour la prévention d'un état hypoglycémique

Country Status (7)

Country Link
US (1) US20100197787A1 (fr)
EP (1) EP1935417A4 (fr)
JP (1) JPWO2007043363A1 (fr)
KR (1) KR20080064834A (fr)
CN (1) CN101287458A (fr)
TW (1) TW200800153A (fr)
WO (1) WO2007043363A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI503128B (zh) 2007-07-31 2015-10-11 Ajinomoto Kk A granule preparation containing an amino acid with excellent taste
PT2098125E (pt) * 2008-03-03 2011-11-15 Nestec Sa Produto alimentar gelificado com elevada eficiência de ingestão de hidratos de carbono
EP2098124A1 (fr) 2008-03-03 2009-09-09 Nestec S.A. Gel de glucide
WO2012099082A1 (fr) * 2011-01-17 2012-07-26 味の素株式会社 Gelée contenant un acide aminé à chaîne ramifiée
GB201108343D0 (en) 2011-05-18 2011-06-29 Hibernation Honey Ltd Honey composition
KR101352422B1 (ko) * 2011-11-23 2014-01-20 주식회사 아리바이오 저혈당 개선용 조성물
CN102908337B (zh) * 2012-10-12 2014-03-05 大连医诺生物有限公司 微囊化氨基酸组合物及其制备方法
JP5854077B2 (ja) * 2014-04-14 2016-02-09 味の素株式会社 経口摂取用ゲル状組成物、及びその製造方法
JP2023066490A (ja) * 2021-10-29 2023-05-16 花王株式会社 経口用顆粒組成物
IT202200027306A1 (it) * 2022-12-30 2024-06-30 Harmonium Pharma S R L Uso di una specifica associazione di glucosio e colina nel recupero dei sintomi autonomici e neuroglicopenici da ipoglicemia

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003221327A (ja) * 2002-01-25 2003-08-05 Ajinomoto Co Inc 分岐鎖アミノ酸含有チュアブル剤
JP2003221330A (ja) * 2002-01-30 2003-08-05 Ajinomoto Co Inc 分岐鎖アミノ酸を含有するゼリー剤
EP1591116A1 (fr) * 2003-02-06 2005-11-02 Otsuka Pharmaceutical Factory, Inc. Inhibiteur de l'augmentation du taux de glycemie peri-operatoire

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501564A (ja) 1984-03-01 1986-07-31 ア−ク，バ−ノン 老人の記憶疾患の治療方法
AU598443B2 (en) 1984-03-01 1990-06-28 Vernon Erk A method of treating hypoglycemia in vertebrates
JPH02172915A (ja) 1988-12-23 1990-07-04 Ajinomoto Co Inc 脳細胞代謝改善組成物
JPH03275631A (ja) 1990-03-19 1991-12-06 Ajinomoto Co Inc 抗痴呆薬
JP4281281B2 (ja) 2002-01-30 2009-06-17 味の素株式会社 分岐鎖アミノ酸を含有するドライシロップ剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003221327A (ja) * 2002-01-25 2003-08-05 Ajinomoto Co Inc 分岐鎖アミノ酸含有チュアブル剤
JP2003221330A (ja) * 2002-01-30 2003-08-05 Ajinomoto Co Inc 分岐鎖アミノ酸を含有するゼリー剤
EP1591116A1 (fr) * 2003-02-06 2005-11-02 Otsuka Pharmaceutical Factory, Inc. Inhibiteur de l'augmentation du taux de glycemie peri-operatoire

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DOI MASAKO ET AL: "Isoleucine-stimulated glucose uptake in skeletal muscle results in down-regulation of AMPK in vivo", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD, US, vol. 19, no. 4, Suppl.S, 1 March 2005 (2005-03-01), pages A196, XP009116005, ISSN: 0892-6638 *
JAVIER Z ET AL: "Leucine-sensitive hypoglycemia - Treatment with zinc glucagon and corticosteroids", AMERICAN JOURNAL OF MEDICINE, XX, XX, vol. 41, no. 4, 1 October 1966 (1966-10-01), pages 638 - 644, XP023220809, ISSN: 0002-9343, [retrieved on 19661001] *
See also references of WO2007043363A1 *

Also Published As

Publication number Publication date
WO2007043363A1 (fr) 2007-04-19
KR20080064834A (ko) 2008-07-09
US20100197787A1 (en) 2010-08-05
CN101287458A (zh) 2008-10-15
JPWO2007043363A1 (ja) 2009-04-16
TW200800153A (en) 2008-01-01
EP1935417A1 (fr) 2008-06-25

Similar Documents

Publication Publication Date Title
EP1935417A4 (fr) Composition à utiliser pour la prévention d'un état hypoglycémique
WO2008057802A3 (fr) Compositions comprenant des agents d'inhibition de la pompe à protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procédés d'utilisation
WO2006096439A3 (fr) Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
EP1864665A4 (fr) Agent immunosuppressif et agent anti-tumoral comprenant un compose heterocyclique en tant que principe actif
WO2007129195A3 (fr) 4-pyrimidine-5-amino-pyrazoles
WO2011058474A8 (fr) Inhibiteurs de n1-pyrazolospirocétone acétyl-coa carboxylase
WO2007014258A3 (fr) Secretagogues de l'hormone de croissance
WO2008088030A1 (fr) Composition destinée à la prévention ou au traitement d'une maladie associée à un thrombus ou à un embole
WO2009027820A3 (fr) Composés de pipéridine de type quinoxaline substituée et leurs utilisations
WO2008131860A3 (fr) Pyridone-carboxamides, phytoprotecteurs contenant ces composés, procédés pour leur production et leur utilisation
WO2007124465A3 (fr) Formules d'émulsions stables
WO2009132785A8 (fr) Esters et thio-esters d'acide thiazol-4-carboxylique utilisés comme agents phytosanitaires
WO2008070368A3 (fr) Procédés et compositions pour le soin de la peau
WO2007122580A3 (fr) Compositions et méthodes utiles dans le traitement de maladies respiratoires
WO2008128775A3 (fr) Composition pharmaceutique stabilisée contenant de la prégabaline
WO2008143240A1 (fr) Préparation orale renfermant un acide organique spécifique et procédé d'amélioration de la propriété d'élution et de la stabilité chimique de la préparation orale
WO2008073332A3 (fr) Compositions de créatine pour traitement cutané
WO2008042619A3 (fr) Compositions pharmaceutiques aqueuses à conservation spontanée
WO2006127379A3 (fr) Composes modulant par2 et leur utilisation
WO2005077103A3 (fr) Compositions et methodes de modification et de prevention de l'infectiosite du coronavirus du sras
WO2008079610A3 (fr) Nouveaux inhibiteurs d'acétyl-coa-carboxylase (acc) et utilisation dans le traitement du diabète, de l'obésité et du syndrome métabolique
WO2011076209A3 (fr) Composition pharmaceutique comprenant un mélange de solvants et un dérivé de la vitamine d ou analogue
WO2009051223A1 (fr) Composition pharmaceutique pour le traitement de la cataracte
WO2009038412A3 (fr) Composés inhibiteurs de la béta-sécrétase
EP2077111A4 (fr) Agent antidépresseur

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080319

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20090511

17Q First examination report despatched

Effective date: 20090727

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100708